Committee members disclosed the following covering the period 12 months before December 2019
| Member . | Employment . | Research grant . | Other research support . | Speakers’ bureau/honoraria . | Ownership interest . | Consultant/advisory board . | Other . |
|---|---|---|---|---|---|---|---|
| Professional Practice Committee | |||||||
| Joshua J. Neumiller, PharmD, CDE, FASCP, Chair | Washington State University | None | None | Diabetes Spectrum, Associate Editorship | None | None | None |
| George Bakris, MD | University of Chicago Medicine | Bayer, Janssen, Vascular Dynamics# | None | None | None | Novo Nordisk, Merck, KBP Biosciences | None |
| William T. Cefalu, MD | National Institute of Diabetes and Digestive and Kidney Diseases | None | None | None | None | None | None |
| Jill Crandall, MD | Albert Einstein College of Medicine | None | None | None | None | None | None |
| David D'Alessio, MD | Duke University, Division of Endocrinology | Merck, Eli Lilly | None | Novo Nordisk | None | Lilly, Intarcia | Endocrine Society Meeting Committee |
| Jennifer Green, MD | Duke University, Division of Endocrinology | Boehringer Ingelheim | None | None | None | Boehringer Ingelheim*, Novo Nordisk, Astra Zeneca | None |
| Elbert Huang, MD, MPH, FACP | University of Chicago Medicine | None | None | None | GlaxoSmithKline* | None | Medical Research Analytics and Informatics Alliance, Board of Directors; The Institute for Clinical and Economic Review, Midwest Comparative Effectiveness Public Advisory Council |
| Kathryn Evans Kreider, DNP, APRN, FNP- BC, BC-ADM | Duke University Medical Center, Division of Endocrinology | None | None | None | None | Amgen | None |
| Christine G. Lee, MD, MS | National Institute of Diabetes and Digestive and Kidney Diseases, Division of Diabetes, Endocrinology, and Metabolic Diseases | None | None | None | None | None | ADA Precision Medicine and Diabetes Task Force Steering Committee |
| Nisa Maruthur, MD, MHS | Johns Hopkins University, Division of General Internal Medicine | None | None | None | None | None | None |
| Anne Peters, MD | Keck School of Medicine of University of Southern California | Dexcom#, vTv Therapeutics# | None | ADA Scientific Sessions 2019 (honorarium returned to ADA as charitable donation) | Stock options | Abbott Diabetes Care, Boehringer Ingelheim, Eli Lilly, Lexicon, Livongo, Medscape*, MannKind, Novo Nordisk, Sanofi* | None |
| Maria Jose Redondo, MD, PhD, MPH | Texas Children's Hospital-Baylor College of Medicine | Caladrius# | None | ADA Scientific Sessions 2019 | None | None | TrialNet Steering Committee member |
| Jane Reusch, MD | University of Colorado | None | None | Sanofi keynote address# | None | Medtronic | None |
| Emily Weatherup, MS, RDN, CDE | University of Michigan | None | None | ADA Scientific Sessions 2019 | None | None | None |
| Jennifer Wyckoff, MD | University of Michigan | None | None | ADA speaker honoraria | None | EPIC Endocrine Steering Committee member | None |
| Deborah Young-Hyman, PhD, CDE | National Institutes of Health, Office of Behavioral Health and Social Science Research | None | None | None | None | None | None |
| American College of Cardiology—Designated Representatives (Section 10) | |||||||
| Sandeep Das, MD, MPH, FACC | University of Texas Southwestern Medical Center | None | None | Circulation (Associate Editor) | None | None | None |
| Mikhail Kosiborod, MD, FACC | Saint Luke’s Mid America Heart Institute | AstraZeneca*, Boehringer Ingelheim* | AstraZeneca*# | None | None | AstraZeneca*, Sanofi*, GlaxoSmithKline, Amgen*, Boehringer Ingelheim*, Novo Nordisk*, Merck (Diabetes)*, Eisai*, Glytec, Janssen*, Intarcia Therapeutics, Novartis, Bayer, Applied Therapeutics | None |
| American Diabetes Association Staff | |||||||
| Kenneth P. Moritsugu, MD, MPH | American Diabetes Association, First Samurai Consulting, LLC | None | None | None | First Samurai Consulting, LLC | None | None |
| Mindy Saraco, MHA | American Diabetes Association | None | None | None | None | None | None |
| Malaika I. Hill, MA | American Diabetes Association | None | None | None | None | None | None |
| Matthew P. Petersen | American Diabetes Association | None | None | None | None | None | None |
| Shamera Robinson, MPH, RDN | American Diabetes Association | None | None | None | None | None | None |
| Member . | Employment . | Research grant . | Other research support . | Speakers’ bureau/honoraria . | Ownership interest . | Consultant/advisory board . | Other . |
|---|---|---|---|---|---|---|---|
| Professional Practice Committee | |||||||
| Joshua J. Neumiller, PharmD, CDE, FASCP, Chair | Washington State University | None | None | Diabetes Spectrum, Associate Editorship | None | None | None |
| George Bakris, MD | University of Chicago Medicine | Bayer, Janssen, Vascular Dynamics# | None | None | None | Novo Nordisk, Merck, KBP Biosciences | None |
| William T. Cefalu, MD | National Institute of Diabetes and Digestive and Kidney Diseases | None | None | None | None | None | None |
| Jill Crandall, MD | Albert Einstein College of Medicine | None | None | None | None | None | None |
| David D'Alessio, MD | Duke University, Division of Endocrinology | Merck, Eli Lilly | None | Novo Nordisk | None | Lilly, Intarcia | Endocrine Society Meeting Committee |
| Jennifer Green, MD | Duke University, Division of Endocrinology | Boehringer Ingelheim | None | None | None | Boehringer Ingelheim*, Novo Nordisk, Astra Zeneca | None |
| Elbert Huang, MD, MPH, FACP | University of Chicago Medicine | None | None | None | GlaxoSmithKline* | None | Medical Research Analytics and Informatics Alliance, Board of Directors; The Institute for Clinical and Economic Review, Midwest Comparative Effectiveness Public Advisory Council |
| Kathryn Evans Kreider, DNP, APRN, FNP- BC, BC-ADM | Duke University Medical Center, Division of Endocrinology | None | None | None | None | Amgen | None |
| Christine G. Lee, MD, MS | National Institute of Diabetes and Digestive and Kidney Diseases, Division of Diabetes, Endocrinology, and Metabolic Diseases | None | None | None | None | None | ADA Precision Medicine and Diabetes Task Force Steering Committee |
| Nisa Maruthur, MD, MHS | Johns Hopkins University, Division of General Internal Medicine | None | None | None | None | None | None |
| Anne Peters, MD | Keck School of Medicine of University of Southern California | Dexcom#, vTv Therapeutics# | None | ADA Scientific Sessions 2019 (honorarium returned to ADA as charitable donation) | Stock options | Abbott Diabetes Care, Boehringer Ingelheim, Eli Lilly, Lexicon, Livongo, Medscape*, MannKind, Novo Nordisk, Sanofi* | None |
| Maria Jose Redondo, MD, PhD, MPH | Texas Children's Hospital-Baylor College of Medicine | Caladrius# | None | ADA Scientific Sessions 2019 | None | None | TrialNet Steering Committee member |
| Jane Reusch, MD | University of Colorado | None | None | Sanofi keynote address# | None | Medtronic | None |
| Emily Weatherup, MS, RDN, CDE | University of Michigan | None | None | ADA Scientific Sessions 2019 | None | None | None |
| Jennifer Wyckoff, MD | University of Michigan | None | None | ADA speaker honoraria | None | EPIC Endocrine Steering Committee member | None |
| Deborah Young-Hyman, PhD, CDE | National Institutes of Health, Office of Behavioral Health and Social Science Research | None | None | None | None | None | None |
| American College of Cardiology—Designated Representatives (Section 10) | |||||||
| Sandeep Das, MD, MPH, FACC | University of Texas Southwestern Medical Center | None | None | Circulation (Associate Editor) | None | None | None |
| Mikhail Kosiborod, MD, FACC | Saint Luke’s Mid America Heart Institute | AstraZeneca*, Boehringer Ingelheim* | AstraZeneca*# | None | None | AstraZeneca*, Sanofi*, GlaxoSmithKline, Amgen*, Boehringer Ingelheim*, Novo Nordisk*, Merck (Diabetes)*, Eisai*, Glytec, Janssen*, Intarcia Therapeutics, Novartis, Bayer, Applied Therapeutics | None |
| American Diabetes Association Staff | |||||||
| Kenneth P. Moritsugu, MD, MPH | American Diabetes Association, First Samurai Consulting, LLC | None | None | None | First Samurai Consulting, LLC | None | None |
| Mindy Saraco, MHA | American Diabetes Association | None | None | None | None | None | None |
| Malaika I. Hill, MA | American Diabetes Association | None | None | None | None | None | None |
| Matthew P. Petersen | American Diabetes Association | None | None | None | None | None | None |
| Shamera Robinson, MPH, RDN | American Diabetes Association | None | None | None | None | None | None |
*
≥$10,000 per year from company to individual.
#
Grant or contract is to university or other employer. William T. Cefalu, MD, joined the Professional Practice Committee in August 2019 subsequent to his resignation as Chief Scientific, Medical, and Mission Officer of ADA. Kenneth P. Moritsugu, MD, MPH, FACPM, is currently the Interim Chief Scientific and Medical Officer of ADA and continues his work with First Samurai Consulting, LLC. Prior to joining ADA in September 2019, Malaika I. Hill, MA, was the principal of MD Writing & Editing Solutions, LLC. Jane Reusch, MD, joined the Professional Practice Committee in April 2019. Christine Lee, MD, joined the Professional Practice Committee in June 2019.
© 2019 by the American Diabetes Association.
2019
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
